JANX
Janux Therapeutics Inc Earnings
$13.9
Earnings Summary
Revenue | $7.88Mn |
Net Profits | $-31.95Mn |
Net Profit Margins | -405.41% |
Janux Therapeutics Inc’s revenue jumped 192.58% since last year same period to $7.88Mn in the Q4 2025. On a quarterly growth basis, Janux Therapeutics Inc has generated -21.2% fall in its revenue since last 3-months.
Janux Therapeutics Inc’s net profit fell -58.02% since last year same period to $-31.95Mn in the Q4 2025. On a quarterly growth basis, Janux Therapeutics Inc has generated -31.39% fall in its net profits since last 3-months.
Janux Therapeutics Inc’s net profit margin fell -270.7% since last year same period to -405.41% in the Q4 2025. On a quarterly growth basis, Janux Therapeutics Inc has generated -66.74% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.7 |
EPS Estimate Current Year | -0.7 |
Janux Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.7 - a -13.36% fall from last quarter’s estimates.
Janux Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.7.
Key Ratios
Earning Per Share (EPS) | -0.51 |
Janux Therapeutics Inc’s earning per share (EPS) fell -41.67% since last year same period to -0.51 in the Q4 2025. This indicates that the Janux Therapeutics Inc has generated -41.67% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-11-06 | -0.62 | -0.39 | 36.82% |
2025-08-07 | -0.46 | -0.55 | -19.25% |
2026-02-26 | -0.7 | -0.51 | 27.12% |
2025-05-08 | -0.39 | -0.38 | 2.99% |
